In 2018, a patient with end-stage kidney disease received a genome-edited pig kidney. In 2018, the transplanted kidney began demonstrating signs of failure and the patient resumed dialysis. This represents a new frontier in medicine and demonstrates the potential of genome engineering to change the lives of millions of patients worldwide suffering from kidney failure.